Cargando…

Correction to: Iron chelation may harm patients with COVID-19

Detalles Bibliográficos
Autores principales:	Garrick, Michael D., Ghio, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966893/ https://www.ncbi.nlm.nih.gov/pubmed/33730195 http://dx.doi.org/10.1007/s00228-021-03124-x

Ejemplares similares

Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2020)

Reply: Iron chelation may harm patients with COVID-19
por: Abobaker, Anis
Publicado: (2020)

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
por: Amano, Shogo, et al.
Publicado: (2023)

Correction: Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox
Publicado: (2019)

Correction: Killing wolves to prevent predation on livestock may protect one farm but harm neighbors
por: Santiago-Avila, Francisco J., et al.
Publicado: (2018)

A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese
por: Wolff , Natascha A., et al.
Publicado: (2018)

Iron Chelator or Iron Supplement Consumption in COVID-19? The Role of Iron with Severity Infection
por: Bastin, Alireza, et al.
Publicado: (2021)

Therapeutic potential of induced iron depletion using iron chelators in Covid-19
por: Poonkuzhi Naseef, Punnoth, et al.
Publicado: (2022)

Correction to: Is the literature inconclusive about the harm from HES? No
por: Wiedermann, Christian J., et al.
Publicado: (2020)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
por: Habib, Hosam M., et al.
Publicado: (2021)

Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014)

Iron Chelation in Local Infection
por: Scott, Cassidy, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Conservative Iron Chelation for Neuroferritinopathy
por: Marchand, Felix, et al.
Publicado: (2022)

Correction: Publication reform to safeguard wildlife from researcher harm
por: Field, Kate A., et al.
Publicado: (2020)

Correction to: Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm
por: Lam, Jonathan Yong Jie, et al.
Publicado: (2022)

Correction to: Changes in self-harm- and violence-related urgent psychiatric consultation in the emergency department during the different stages of the COVID-19 pandemic
por: Liu, Chun Hao, et al.
Publicado: (2023)

Author Correction: Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
por: Han, Donghoon, et al.
Publicado: (2023)

Correction to: Changes in inflammatory cytokines, antioxidants and liver stiffness after chelation therapy in individuals with chronic lead poisoning
por: Teerasarntipan, Tongluk, et al.
Publicado: (2021)

Correction: A Novel Copper Chelate Modulates Tumor Associated Macrophages to Promote Anti-Tumor Response of T Cells
Publicado: (2015)

Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy
por: Ghio, Stefano, et al.
Publicado: (2021)

Correction: Occurrence of Harmful Algal Species and Shellfish Toxicity in Sardinia (Italy)
por: Bazzoni, Anna Maria, et al.
Publicado: (2017)

Correction to: The Difficulties of Grandiose Delusions: Harms, Challenges, and Implications for Treatment Engagement
Publicado: (2023)

Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Role of Iron Chelation and Protease Inhibition of Natural Products on COVID-19 Infection
por: Carota, Giuseppe, et al.
Publicado: (2021)

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
por: Abobaker, Anis
Publicado: (2020)

Salivary proline-rich protein may reduce tannin-iron chelation: a systematic narrative review
por: Delimont, Nicole M., et al.
Publicado: (2017)

Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
Publicado: (2020)

Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
por: Sun, Duxin
Publicado: (2020)

Author Correction: Nickel chelation therapy as an approach to combat multi-drug resistant enteric pathogens
por: Benoit, Stéphane L., et al.
Publicado: (2019)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Iron Chelation Therapy in Thalassemia Syndromes
por: Cianciulli, Paolo
Publicado: (2009)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Correction: Harming Ourselves and Defiling Others: What Determines a Moral Domain?
por: Chakroff, Alek, et al.
Publicado: (2013)

The Utility of Iron Chelators in the Management of Inflammatory Disorders
por: Lehmann, C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_11nq7mjdtvvk86lfjis70ajo4a